Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma
Authors
Keywords
Cancer treatment, Apoptosis, Renal cell carcinoma, Gene expression, Specimen preparation and treatment, Microarrays, Surgical oncology, Polymerase chain reaction
Journal
PLoS One
Volume 10, Issue 6, Pages e0130980
Publisher
Public Library of Science (PLoS)
Online
2015-06-27
DOI
10.1371/journal.pone.0130980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interaction between pancreatic cancer cells and tumor-associated macrophages promotes the invasion of pancreatic cancer cells and the differentiation and migration of macrophages
- (2014) Fanbin Meng et al. IUBMB LIFE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
- (2013) Bradford Hall et al. Journal of Translational Medicine
- New Agents for Targeting of IL-13RA2 Expressed in Primary Human and Canine Brain Tumors
- (2013) Waldemar Debinski et al. PLoS One
- New agents in renal cell carcinoma
- (2013) Raetasha Dabney et al. Targeted Oncology
- Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) B. Escudier et al. ANNALS OF ONCOLOGY
- Tumor microvasculature with endothelial fenestrations inVHLnull clear cell renal cell carcinomas as a potent target of anti-angiogenic therapy
- (2012) Toshinari Yamasaki et al. CANCER SCIENCE
- Complete Remission With Tyrosine Kinase Inhibitors in Renal Cell Carcinoma
- (2012) Laurence Albiges et al. JOURNAL OF CLINICAL ONCOLOGY
- A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma
- (2012) S. Sivanand et al. Science Translational Medicine
- A Blueprint for Advancing Genetics-Based Cancer Therapy
- (2011) William R. Sellers CELL
- Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
- (2011) K. J. Gotink et al. CLINICAL CANCER RESEARCH
- MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
- (2011) James Finke et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Silencing IL-13R 2 Promotes Glioblastoma Cell Death via Endogenous Signaling
- (2011) L. C. Hsi et al. MOLECULAR CANCER THERAPEUTICS
- JunB promotes cell invasion and angiogenesis in VHL-defective renal cell carcinoma
- (2011) T Kanno et al. ONCOGENE
- Resistance of Renal Cell Carcinoma to Sorafenib Is Mediated by Potentially Reversible Gene Expression
- (2011) Liang Zhang et al. PLoS One
- Identification of EP4 as a Potential Target for the Treatment of Castration-Resistant Prostate Cancer Using a Novel Xenograft Model
- (2010) N. Terada et al. CANCER RESEARCH
- Interleukin-8 Mediates Resistance to Antiangiogenic Agent Sunitinib in Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review
- (2010) Ketao Jin et al. Clinical & Translational Oncology
- The Immunocytokine F8-IL2 Improves the Therapeutic Performance of Sunitinib in a Mouse Model of Renal Cell Carcinoma
- (2010) Katharina Frey et al. JOURNAL OF UROLOGY
- Reversible Epithelial to Mesenchymal Transition and Acquired Resistance to Sunitinib in Patients with Renal Cell Carcinoma: Evidence from a Xenograft Study
- (2010) H. J. Hammers et al. MOLECULAR CANCER THERAPEUTICS
- Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling
- (2010) R. S. Bhatt et al. MOLECULAR CANCER THERAPEUTICS
- Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells
- (2009) H. Xin et al. CANCER RESEARCH
- Renal cell carcinoma
- (2009) Brian I Rini et al. LANCET
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- Does Arterial Spin-labeling MR Imaging–measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?
- (2009) Rachel Schor-Bardach et al. RADIOLOGY
- Alternative Activation of Macrophages: An Immunologic Functional Perspective
- (2008) Fernando O. Martinez et al. Annual Review of Immunology
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
- Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
- (2008) Haiyen E. Zhau et al. CLINICAL & EXPERIMENTAL METASTASIS
- Clinical effect and future considerations for molecularly-targeted therapy in renal cell carcinoma
- (2008) Brian I. Rini et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now